Calcium as a Mediator of Salt Sensitive Hypertension

  • Lawrence M. Resnick
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 208)


Dietary salt intake has long been recognized as a factor in clinical and experimental hypertensive disease. However, when attention remains narrowly focused on salt and/or sodium alone, the mechanism(s) by which increases in dietary, extracellular, or intracellular sodium lead to increases in blood pressure, still remain unclear. Increased tissue and presumably intracellular sequestration of sodium was initially observed by Tobian (1), accounted for prhps by now widely postulated circulating inhibitors of Na+ -K+ -ATPase, stimulated by the volume expansion of salt loading in salt sensitive hypertensive animals and humans (2). Linking calcium with sodium has led to a further understanding of salt-induced hypertension. Calcium is required as a final common mediator of smooth muscle contraction, and thus of peripheral vasoconstrictor tone, characteristically elevated in human hypertension (3). Parallel studies over the past three decades have also demonstrated the sodium dependence of cellular calcium uptake in arterial smooth muscle (4). This led to the much discussed hypothesis by which this sodium-calcium exchange mechanism may be involved in human hypertension (5).


Plasma Renin Activity Calcium Metabolism Atrial Natriuretic Factor Salt Loading Salt Sensitive Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tobian, L., and J.T. Binion, Tissue cations and water in artieral hypertension, Circulation. 5: 754–758 (1952).Google Scholar
  2. 2.
    MacGregor, G.A. and H.E. deWardener, Is a circulating sodium transport inhibitor involved in the pathogenesis of essential hypertension? Clin. Ex. Hypertens. 3:81–5–830 (1981).Google Scholar
  3. 3.
    Resnick, L.M. and J.H. Laragh, The renin-angiotensin system in pregnancy, in: “Endocrinology of Pregnancy,” F. Fuchs and A. Klopper, eds., Harper and Row (1983).Google Scholar
  4. 4.
    Reuter, H., M.P. Blaustein, G. Hauresler, Na-Ca exchange and tension development in arterial smooth muscle, Phil. Trans. R. Soc. Lond. B. 265: 87–94 (1973).CrossRefGoogle Scholar
  5. 5.
    Blaustein, M.P., Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis, Am. J. Physiol. 232: C165 - C173 (1977).Google Scholar
  6. 6.
    Kleinert, H.D., T. Maack, S.A. Atlas, A. Januszewicz, J.E. Sealey, and J.H. Laragh, Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility, Hypertension. 6:#2(Suppl I ) 143–147 (1984).Google Scholar
  7. 7.
    Tamura, M., H. Kuwano, T. Kinoshite, and T. Inagami, Identification oT linoleic and oleic acids as endogenous Na,K -ATPase inhibitors from acute volume-expanded hog plasma, J. Biol. Chem. 260: 9672–9677 (1985).Google Scholar
  8. 8.
    Brunner, H.R., J.H. Laragh, L. Baer, et al., Essential hypertension: renin and aldosterone, heart attack and stroke, N. Engl. J. Med. 286: 441–449 (1972).CrossRefGoogle Scholar
  9. 9.
    Resnick, L.M., J.H. Laragh, J.E. Sealey, and M.H. Alderman, Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity, N. Engl. J. Med. 309: 888–891 (1983).CrossRefGoogle Scholar
  10. 10.
    Resnick, L.M., and J.H. Laragh, Calcium regulating hormones and renin activity (PRA) are linked in human essential hypetension (EH), IX International Congress of Nephrology, June, 1984.Google Scholar
  11. 11.
    Resnick, L.M., J.E. Sealey, and J.H. Laragh, Short and Long-term oral calcium alters blood pressure (BP) in essential hypertension, Fed. Proc. 42 (3): 300 (1983).Google Scholar
  12. 12.
    Resnick, L.M., J.P. Nicholson, J.E. Sealey, and J.H Laragh, Acute and long-term effects of calcium channel blockade on divalent ions, blood pressure, and plasma renin activity, Clin. Res. 31 (2): 253A (1983).Google Scholar
  13. 13.
    Resnick, L.M., J.P. Nicholson, and J.H. Laragh, Outpatient therapy of essential hypertension with dietary calcium supplementation, J. Am. Coll. Card. 3: 616 (1984).Google Scholar
  14. 14.
    Schneid amain n, R.J., S.A. pnn, and D.A. McCarron, Enchancement of CaAntihypertensive action in the SHR by Dietary Na’, IXth International Cong. Nephrology (Los Angeles), June, 1984.Google Scholar
  15. 15.
    Nicholson, J.P., L.M. Resnick, and J.H. Laragh, Sodium balance and the antihypertensive efficacy of verapamil. The Sixth Scientific Meeting of the Inter-American Society of Hypertension, Hypertension, (in press).Google Scholar
  16. 16.
    Kurtz, T.W., and R.C. Morris, Dietary NaC1 as a determinant of disordered calcium metabolism in the Dahl salt-sensitive rat, Kidney Internat. 27: 194 (1985).Google Scholar
  17. 17.
    Resnick, L.M., J.P. Nicholson, and J.H. Laragh, Alterations in calcium metabolism mediate dietary sodium sensitivity. Clin. Res, 33: 608A (1985).Google Scholar
  18. 18.
    Resnick, L.M., J.P. Nicholson, and J.H. Laragh, Sodium sensitivity and calcium metabolism in essential hypertension, Circulation, 70: 11–1 (1984).Google Scholar
  19. 19.
    McCarron, D.A., L.I. Rankin, W.M. Bennett, S. Krutzik, M.R. McClung, and F.C. Luft, Urinary calcium at extremes of sodium intake in normal man. Am. J. Nephrol. 1: 84 (1981).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Lawrence M. Resnick
    • 1
  1. 1.Cardiovascular CenterThe New York Hospital-Cornell Medical CenterNew YorkUSA

Personalised recommendations